The expression and signification of NET-1 in endometrial carcinoma
Xiaohua Song, Dianzhong Geng, Honghua Yin, Xia Wang
Abstract
Xiaohua Song, Dianzhong Geng, Honghua Yin, Xia Wang
Abstract
Objective To study the expression and potential significance of NET-1 in endometrial carcinoma.Methods 106 specimens after operation were selected.All specimens were stained with H.E.and immunohistochemistry.Results The expression of NET-1 immunoreactivity were different in normal endometrium(43.8% ),endometrial hyperplasia ( 79.2% ) and endometrial carcinoma ( 100% ) ( x2 =11.88,P < 0.01 ).The expression of NET-1 in endometrial carcinoma was significantly higher than that in normal endometrium and simple endometrial hyperplasia ( x2 =36.14,10.86,P < 0.01 ).The expression of NET-1 in endometrial hyperplasia was significantly higher than that in normal endometrium ( x2 =5.29,P< 0.05 ).There was a correlation between the expression of NET-1 and degree of endometrial lesions ( r =0.355,P <0.01 ).The expression of NET-1 was relative with differentiation (x2 =11.04,P <0.01 ; r =0.558,P <0.01),stages(x2 =11.04,P <0.01; r =0.558,P <0.01),depth of myometrial invasion (x2 =15.90,P <0.01 ; r =0.479,P <0.01),with or without metastasis in lymph node ( Z =-3.74,P <0.01 ),menopause condition ( Z.=-2.60,P <0.01).Conclusions NET-1 may play an important role in carcinogenesis and progression of endometrial carcinoma.It might be a marker of biological behavior and reference for endometrial carcinoma gene therapy. Key words: Endometrial neoplasms/ME ; Oncogene proteins/ME
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the expression and potential significance of NET-1 in endometrial carcinoma.Methods 106 specimens after operation were selected.All specimens were stained with H.E.and immunohistochemistry.Results The expression of NET-1 immunoreactivity were different in normal endometrium(43.8% ),endometrial hyperplasia ( 79.2% ) and endometrial carcinoma ( 100% ) ( x2 =11.88,P < 0.01 ).The expression of NET-1 in endometrial carcinoma was significantly higher than that in normal endometrium and simple endometrial hyperplasia ( x2 =36.14,10.86,P < 0.01 ).The expression of NET-1 in endometrial hyperplasia was significantly higher than that in normal endometrium ( x2 =5.29,P< 0.05 ).There was a correlation between the expression of NET-1 and degree of endometrial lesions ( r =0.355,P <0.01 ).The expression of NET-1 was relative with differentiation (x2 =11.04,P <0.01 ; r =0.558,P <0.01),stages(x2 =11.04,P <0.01; r =0.558,P <0.01),depth of myometrial invasion (x2 =15.90,P <0.01 ; r =0.479,P <0.01),with or without metastasis in lymph node ( Z =-3.74,P <0.01 ),menopause condition ( Z.=-2.60,P <0.01).Conclusions NET-1 may play an important role in carcinogenesis and progression of endometrial carcinoma.It might be a marker of biological behavior and reference for endometrial carcinoma gene therapy. Key words: Endometrial neoplasms/ME ; Oncogene proteins/ME
Key concepts: Carcinoma, Endometrium, Atypical hyperplasia, Immunohistochemistry, Medicine, Endometrial hyperplasia, Hyperplasia, Lymph node metastasis